Revenue
1.31 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 1306610 USD Source
Annual consolidated revenue for 2025: about USD 590.1K, using the latest reported figures. The previous period, 2023, was about USD 1.713M.
3984453 USD
6153780 shares
316.48% · 4.68 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
2.58 million USD
2025-07-01 – 2026-06-30
-13.5 million USD
2025-07-01 – 2026-06-30
-8.21 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-28.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 6.25 million
–
Current period
−USD 7.75 million
–
-7747813 − -6245737 = -1502076 USD
-6245737 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-7747813 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 5.49 million
–
Current period
−USD 5.93 million
–
-5933881 − -5486980 = -446901 USD
-5486980 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5933881 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 9,160
–
Current period
USD 442,255
–
442255 − 9160 = 433095 USD
9160 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source442255 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 766277 | 2557318 Derived | -1791041 | 9227 Derived | -1800268 | -1621403 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 1712595 | 5478806 Derived | -3766211 | 535306 Derived | -4301517 | -4568002 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 590084 | Unavailable | Unavailable | Unavailable | -7747813 | -6376136 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 766277 |
|
| 2023 | Revenue | 1712595 |
|
| 2025 | Revenue | 590084 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 123.5% |
|
| 2025 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | -233.7% |
|
| 2023 | Operating margin | -219.9% |
|
| 2025-12-31 | Operating margin | Not reported |
|
| 2022 | Net margin | -234.9% |
|
| 2023 | Net margin | -251.2% |
|
| 2025 | Net margin | -1,313% |
|
| 2022 | Free cash flow margin | -211.6% |
|
| 2023 | Free cash flow margin | -266.7% |
|
| 2025 | Free cash flow margin | -1,080.5% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | -1585876 |
|
| 2023 | Operating cash flow | -4556811 |
|
| 2025 | Operating cash flow | -5933881 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | -1621403 |
|
| 2023 | Free cash flow | -4568002 |
|
| 2025 | Free cash flow | -6376136 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Liabilities / assets | 40.2% |
|
| 2023 | Liabilities / assets | 26.3% |
|
| 2025 | Liabilities / assets | 39.1% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Current assets / current liabilities | 2.64× |
|
| 2023 | Current assets / current liabilities | 3.79× |
|
| 2025 | Current assets / current liabilities | 1.74× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | −USD 1.8 million Exact valueExact value: -1800268 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.59 million Exact valueExact value: -1585876 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 35,527 Exact valueExact value: 35527 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.62 million Calculation and evidence-1585876 − 35527 USD Exact free cash flow: -1621403 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 4.3 million Exact valueExact value: -4301517 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.56 million Exact valueExact value: -4556811 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11,191 Exact valueExact value: 11191 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.57 million Calculation and evidence-4556811 − 11191 USD Exact free cash flow: -4568002 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 6.25 million Exact valueExact value: -6245737 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.49 million Exact valueExact value: -5486980 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9,160 Exact valueExact value: 9160 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.5 million Calculation and evidence-5486980 − 9160 USD Exact free cash flow: -5496140 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 7.75 million Exact valueExact value: -7747813 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.93 million Exact valueExact value: -5933881 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 442,255 Exact valueExact value: 442255 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.38 million Calculation and evidence-5933881 − 442255 USD Exact free cash flow: -6376136 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
31 filings · 962 latest values · 962 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001840563, 1840563, ELAB, edgar:1840563
Also known as ELEVAI LABS INC., Elevai Labs Inc., PMGC HOLDINGS INC., PMGC Holdings Inc., Reactive Medical Labs Inc.